Bastide Le Confort MedicalFRA:1DJ -0.62%71 ROA % is 9.52% as of Dec. 2025, which is 321% above its 10-year median of 2.26. GuruFocus rates FRA:1DJ with a GF Score™ of 71/100 and a GF Value™ of €25.12 (Fairly Valued). The stock has 2 warning signs investors should review. Among 118 Medical Distribution companies, Bastide Le Confort Medical ranks better than 76.27% on this metric.
ROA % is calculated as Net Income divided by its average Total Assets over a certain period of time. Bastide Le Confort Medical's annualizedNet Income for the quarter that ended in Dec. 2025 was €59.1 Mil.
Bastide Le Confort Medical's average Total Assets over the quarter that ended in Dec. 2025 was €620.8 Mil. Therefore, Bastide Le Confort Medical's annualized ROA % for the quarter that ended in Dec. 2025 was 9.52%.
The historical rank and industry rank for Bastide Le Confort Medical's ROA % or its related term are showing as below:
FRA:1DJ'
s ROA % Range Over the Past 10 Years
Min: -0.14 Med: 2.26 Max: 4.61
Current: 4.61
During the past 13 years, Bastide Le Confort Medical's highest ROA % was 4.61%. The lowest was -0.14%. And the median was 2.26%.
FRA:1DJ's ROA % is ranked better than 76.27% of 118
companies
in the Medical Distribution industry
Industry Median: 2.215
vs FRA:1DJ: 4.61
Bastide Le Confort Medical (FRA:1DJ) ROA % Explanation
ROA % measures the rate of return on the total assets (shareholder equity plus liabilities). It measures a firm's efficiency at generating profits from shareholders' equity plus its liabilities. ROA % shows how well a company uses what it has to generate earnings. ROA %s can vary drastically across industries. Therefore, ROA % should not be used to compare companies in different industries. For retailers, a ROA % of higher than 5% is expected. For example, Wal-Mart (WMT) has a ROA % of about 8% as of 2012. For banks, ROA % is close to their interest spread. A banks ROA % is typically well under 2%.
Similar to ROE, ROA % is affected by profit margins and asset turnover. This can be seen from the Du Pont Formula:
Note:
The Net Income data used here is two times the semi-annual (Dec. 2025) net income data. The Revenue data used here is two times the semi-annual (Dec. 2025) revenue data.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
Like ROE, ROA % is calculated with only 12 months data. Fluctuations in the company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective. ROA % can be affected by events such as stock buyback or issuance, and by goodwill, a company's tax rate and its interest payment. ROA % may not reflect the true earning power of the assets. A more accurate measurement is ROC % (ROC).
Many analysts argue the higher return the better. Buffett states that really high ROA % may indicate vulnerability in the durability of the competitive advantage.
E.g. Raising $43b to take on KO is impossible, but $1.7b to take on Moody's is. Although Moody's ROA % and underlying economics is far superior to Coca Cola, the durability is far weaker because of lower entry cost.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Distribution subindustry, Bastide Le Confort Medical's ROA %, along with its competitors' market caps and ROA % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Bastide Le Confort Medical ROA % vs Medical Distribution Industry
For the Medical Distribution industry and Healthcare sector, Bastide Le Confort Medical's ROA % distribution charts can be found below:
* The bar in red indicates where Bastide Le Confort Medical's ROA % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of annual ROA %, the net income of the last fiscal year and the average total assets over the fiscal year are used. In calculating the quarterly data,
the Net Income data used here is two times the semi-annual (Dec. 2025) net income data.
ROA % is displayed in the 30-year financial page.
Bastide Le Confort Medical (FRA:1DJ) has a ROA % of 9.52% as of Dec. 2025. Return on assets is the ratio of current-period net income to average two-period total assets. View historical data on Bastide Le Confort Medical and its competitors. This is 321% above median its historical median of 2.26. According to the industry distribution chart, Bastide Le Confort Medical ranks #28 out of 118 companies in the Medical Distribution industry, placing it in the top 23.7%.
Is Bastide Le Confort Medical's ROA % too high?
Bastide Le Confort Medical's current ROA % of 9.52% is 321% above median its 10-year median of 2.26. The Medical Distribution industry median ROA % is 2.22. Bastide Le Confort Medical's value of 9.52% is 329.8% above this industry median. Based on the distribution chart, Bastide Le Confort Medical ranks #28 out of 118 companies in the Medical Distribution industry, which is in the top quartile — a strong position relative to peers. Overall, Bastide Le Confort Medical has a GF Score™ of 71/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Bastide Le Confort Medical's ROA % compare to MCK and CAH?
According to the Medical Distribution industry distribution chart, Bastide Le Confort Medical ranks #28 out of 118 companies for ROA %. This places Bastide Le Confort Medical in the top 24% of its industry — outperforming the majority of peers. The industry median ROA % is 2.22. Bastide Le Confort Medical's value of 9.52% is 329.8% above this benchmark. While the company's 10-year median is 2.26 vs. the industry median of 2.22, Bastide Le Confort Medical has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROA % for a Medical Distribution company?
The median ROA % among Medical Distribution companies is 2.22, based on 118 companies in the industry. Companies in the top quartile (top 25%) have a ROA % significantly above this median, while those in the bottom quartile fall well below. However, ROA % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Bastide Le Confort Medical's current ROA % of 9.52% is 329.8% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROA % mean?
A high ROA % can signal that a stock is expensive relative to its fundamentals. Return on assets is the ratio of current-period net income to average two-period total assets. View historical data on Bastide Le Confort Medical and its competitors. For the Medical Distribution industry, the median ROA % is 2.22 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Bastide Le Confort Medical's current ROA % is 9.52%, which is 321% above median its own 10-year median of 2.26. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Bastide Le Confort Medical stock overvalued right now?
Based on GuruFocus' analysis, Bastide Le Confort Medical (FRA:1DJ) is currently considered Fairly Valued. The stock's GF Value™ is €25.12, compared to a current price of €24.20 — trading 3.7% below its estimated fair value. The current ROA % is 9.52%, which is 321% above median its 10-year median of 2.26 and 329.8% above the Medical Distribution industry median of 2.22. Bastide Le Confort Medical's overall GF Score™ is 71/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROA % calculated?
ROA % is calculated from a company's financial statements. For Bastide Le Confort Medical (FRA:1DJ), the current ROA % is 9.52% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Bastide Le Confort Medical (FRA:1DJ) Overvalued in 2026?
Based on GuruFocus' analysis, Bastide Le Confort Medical stock appears to be undervalued.
The current stock price of €24.20 is trading 3.7% below its estimated GF Value™ of €25.12.
GuruFocus considers Bastide Le Confort Medical to be Fairly Valued.
Key valuation signals for FRA:1DJ:
ROA %: 9.52% (321% above median its 10-year median of 2.26)
GF Value™: €25.12 vs. price of €24.20 (3.7% below fair value)
Industry Position: 329.8% above the Medical Distribution median (#28 of 118)
No single metric tells the full story. See the FRA:1DJ stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Bastide Le Confort Medical SA is a France-based company that is engaged in the sale and rental of medical supplies and equipment for the home care of the elderly, sick and disabled. The company provides care equipment, such as hospital beds, personal assistance products, nutrition, insulin pumps, and syringe-drivers.
71GF Score
Get the complete analysis for FRA:1DJ
ROA % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:1DJ has been successfully added to your 
